← Leaderboards
Xiaohui Wang
East Tennessee State University
$1,835,818
Attributed
$1,835,818
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $952.6K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,835,818 · 3
By mechanism
R01$941,518 · 1
S10$481,800 · 1
R21$412,500 · 1
Top collaborators
No co-investigators on record.
Most similar at East Tennessee State University
Same institution · by research overlap
- David L. Williams$8,988,272
- Chuanfu Li$11,328,649
- Donald B Hoover$2,181,608
- Zhi Q. Yao$6,116,789
Others in their field
Other Rising Stars on “Innovative Therapy”
- Mari Ostendorf · University Of Washington$51,931,230
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Jinsy Andrews · Columbia University Health Sciences$15,416,681
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Innovative TherapyCause Of DeathTranscription FactorGenetic TranscriptionExhibitsImmuneFunctional DisorderImpairmentPlayEndothelial CellsMetabolicCardiovascular SystemPhenotypeMaintenanceCardiacCell Cycle ArrestAge RelatedCell PhysiologyAffectAntigen-Antibody ComplexAcetyl Coenzyme ACell Senescence InductionCapillarityBlood Glucose Regulation
Grant awards (5)
Request for the Acquisition of a Vevo F2 Ultrasound Imaging System$481,800
S10 · FY2025 · OD · contact PI
Novel role of LSECs in hepatic immune and metabolic function during sepsis$470,759
R01 · FY2025 · DK · contact PI
Novel role of LSECs in hepatic immune and metabolic function during sepsis$470,759
R01 · FY2024 · DK · contact PI
Role of endothelial cell senescence in age-related cardiomyopathy$187,500
R21 · FY2024 · AG · contact PI
Role of endothelial cell senescence in age-related cardiomyopathy$225,000
R21 · FY2023 · AG · contact PI